All In Biotech

Free tool

FAERS Monitor: Technescan Pyp Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017538 or its brand name (Technescan Pyp Kit, Technetium Tc-99m Pyrophosphate Kit). Reports on generic versions are filed under their own applications.

Reports

33

Serious

25

76% of reports

Hospitalization

9

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dizziness6
  • hyperhidrosis6
  • syncope5
  • vomiting5
  • drug ineffective3
  • dyspnoea3
  • hypotension3
  • loss of consciousness3
  • blood pressure decreased2
  • body temperature increased2
  • cardiac arrest2
  • cold sweat2
  • feeling hot2
  • flushing2
  • nausea2

Reports by year received

View as table
YearReports
20152
20171
20183
20193
202019
20211
20222
20241
20251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,126 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cold sweat272.318.978
body temperature increased262.516.367
syncopeSignal531.814.2121
hyperhidrosisSignal629.714.4140
feeling hot220.85.421
blood pressure decreased219.25.019
cardiac arrest215.44.015
loss of consciousnessSignal314.95.126
flushing212.53.311
hypotensionSignal39.53.215
dizzinessSignal67.73.729
vomitingSignal56.83.020
dyspnoea33.41.13
nausea21.60.40
drug ineffective31.50.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.